Old Web
English
Sign In
Acemap
>
authorDetail
>
I. Melezinek
I. Melezinek
Medicine
Internal medicine
Oncology
Urology
ZD6126
4
Papers
71
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Сравнительный анализ результатов монотерапии бикалютамидом и кастрации у больных неметастатическим местно-распространенным раком предстательной железы при сроке наблюдения 6,3 года
2008
P. Iversen
C J Tyrrel
A. Kaisary
John Anderson
H. Van Poppel
Tammela T L J
M. Chamberlain
K Carrol
I. Melezinek
Show All
Source
Cite
Save
Citations (0)
Evaluation of the role of body-surface-area dose adjustment of ZD6126, a novel vascular-targeting agent
2004
Journal of Clinical Oncology
R. Oliver
Catherine Wheeler
Peter Langmuir
I. Melezinek
Andrew Stone
Show All
Source
Cite
Save
Citations (2)
The non-steroidal antiandrogen, bicalutamide ('Casodex'), may preserve bone mineral density as compared with castration: results of a preliminary study
2003
World Journal of Urology
C. Tyrrell
Glen M. Blake
Peter Iversen
Amir V. Kaisary
I. Melezinek
Show All
Source
Cite
Save
Citations (16)
The role of prostate specific antigen measurement in the detection and management of prostate cancer.
2000
Endocrine-related Cancer
A F Nash
I. Melezinek
Show All
Source
Cite
Save
Citations (53)
1